Entos Pharmaceuticals
PrivateLast Round
Grant
Aug 1, 2025
Total Funding Raised
$63.81M
Momentum Score
25 /100
Company Overview
Entos Pharmaceuticals is a clinical-stage genetic medicines company developing therapies using its proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Entos Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Entos Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 1, 2025 | ||||
| Early Funding | May 22, 2025 | ||||
| Grant | Mar 11, 2025 | ||||
| Grant | Feb 5, 2025 | ||||
| Grant | Oct 7, 2023 | ||||
Grant | Dec 1, 2021 |
Entos Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian International Innovation Program | Grant |
| CureDuchenne Ventures | Early Funding |
| National Research Council Canada | Grant |
| Government of Canada | Grant |
| Government of Alberta | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Developing a curative therapy for LMNA-Related Congenital Muscular Dystrophy.
- Apr 20, 2026
Partnered with L-CMD Research Foundation to develop curative therapy.
Entos Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Entos Pharmaceuticals's valuation, stock price, and market status.
